Blue Stream Buys Agilent's Mass Spec, HPLC Tools for Proteomics Services | GenomeWeb
NEW YORK (GenomeWeb News) — Blue Stream Laboratories has purchased a suite of Agilent Technologies’ proteomics products for its drug-development work, Agilent said today.
 
Boston-based Blue Stream has stocked its protein-characterization lab with Agilent's HPLC-chip and its 6210 time-of-flight mass spectrometer with MALDI and electrospray capabilities.
 
The deal also includes software and services that support the technology, Agilent said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.